• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Neurodegenerative Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global neurodegenerative disease treatment market grew at a CAGR of around 8% during 2015-2020. Neurodegenerative diseases refer to a group of brain disorders that lead to progressive degeneration of the structure and function of neurons in the central nervous system (CNS) or peripheral nervous system (PNS). Presently, several medications are available to reduce physical or mental symptoms and improve the quality of patients' life. Moreover, researchers are focusing on developing molecular diagnostics, especially biomarkers and imaging spectroscopy, to detect and diagnose neurodegenerative diseases at an early stage and prevent their progression.

The growing prevalence of tumors and stroke on account of excessive alcohol consumption, in confluence with the rising geriatric population, represents one of the major factors increasing the risk of developing neurodegenerative diseases. This is further escalating the need for molecular diagnostic techniques for early diagnosis of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. Apart from this, researchers are combining neuropathological methods with molecular biology techniques to understand the classification of these diseases effectively. They are also developing minimally invasive (MI) screening tests for different types of neurodegenerative diseases. Furthermore, governing agencies of numerous countries, along with non-governmental organizations (NGOs), are supporting various health education campaigns to generate awareness about the risk factors of neurodegenerative diseases. Other factors, such as increasing access to healthcare facilities on account of improving infrastructure and inflating disposable incomes, are anticipated to drive the growth of the market in the coming years. Looking forward, IMARC Group expects the global neurodegenerative disease treatment market to exhibit moderate growth during the next five years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global neurodegenerative disease treatment market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, indication, drug type, route of administration and distribution channel.

Breakup by Indication:

  • Multiple Sclerosis
  • Parkinsons Disease
  • Alzheimers Disease
  • Spinal Muscular Atrophy (SMA)
  • Huntingtons Disease
  • Others
     

Breakup by Drug Type:

  • N-methyl-D-aspartate Receptor antagonists
  • Selective Serotonin Reuptake Inhibitors
  • Dopamine Inhibitors
  • Others
     

Breakup by Route of Administration:

  • Oral
  • Injectable
  • Others
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Biogen, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc , Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A, Teva Pharmaceutical Industries Ltd. and UCB S.A.

Key Questions Answered in This Report:

  • How has the global neurodegenerative disease treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global neurodegenerative disease treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global neurodegenerative disease treatment market and who are the key players?
  • What is the degree of competition in the industry?

1   Preface
2   Scope and Methodology

    2.1   Objectives of the Study
    2.2   Stakeholders
    2.3   Data Sources
        2.3.1   Primary Sources
        2.3.2   Secondary Sources
    2.4   Market Estimation
        2.4.1   Bottom-Up Approach
        2.4.2   Top-Down Approach
    2.5   Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1   Overview
    4.2   Key Industry Trends
5   Global Neurodegenerative Disease Treatment Market
    5.1   Market Overview
    5.2   Market Performance
    5.3   Impact of COVID-19
    5.4   Market Forecast
6    Market Breakup by Indication
     6.1   Multiple Sclerosis
        6.1.1  Market Trends
        6.1.2  Market Forecast
     6.2   Parkinsons Disease
        6.2.1  Market Trends
        6.2.2  Market Forecast
     6.3   Alzheimers Disease
        6.3.1  Market Trends
        6.3.2  Market Forecast
     6.4   Spinal Muscular Atrophy (SMA)
        6.4.1  Market Trends
        6.4.2  Market Forecast
     6.5   Huntingtons Disease
        6.5.1  Market Trends
        6.5.2  Market Forecast
     6.6   Others
        6.6.1  Market Trends
        6.6.2  Market Forecast
7    Market Breakup by Drug Type
     7.1   N-methyl-D-aspartate Receptor antagonists
        7.1.1  Market Trends
        7.1.2  Market Forecast
     7.2   Selective Serotonin Reuptake Inhibitors
        7.2.1  Market Trends
        7.2.2  Market Forecast
     7.3   Dopamine Inhibitors
        7.3.1  Market Trends
        7.3.2  Market Forecast
     7.4   Others
        7.4.1  Market Trends
        7.4.2  Market Forecast
8    Market Breakup by Route of Administration
     8.1   Oral
        8.1.1  Market Trends
        8.1.2  Market Forecast
     8.2   Injectable
        8.2.1  Market Trends
        8.2.2  Market Forecast
     8.3   Others
        8.3.1  Market Trends
        8.3.2  Market Forecast
9    Market Breakup by Distribution Channel
     9.1   Hospital Pharmacies
        9.1.1  Market Trends
        9.1.2  Market Forecast
     9.2   Retail Pharmacies
        9.2.1  Market Trends
        9.2.2  Market Forecast
     9.3   Others
        9.3.1  Market Trends
        9.3.2  Market Forecast
10    Market Breakup by Region
     10.1   North America
          10.1.1   United States
               10.1.1.1  Market Trends
               10.1.1.2  Market Forecast
          10.1.2   Canada
               10.1.2.1  Market Trends
               10.1.2.2  Market Forecast
     10.2   Asia-Pacific
          10.2.1   China
               10.2.1.1  Market Trends
               10.2.1.2  Market Forecast
          10.2.2   Japan
               10.2.2.1  Market Trends
               10.2.2.2  Market Forecast
          10.2.3   India
               10.2.3.1  Market Trends
               10.2.3.2  Market Forecast
          10.2.4   South Korea
               10.2.4.1  Market Trends
               10.2.4.2  Market Forecast
          10.2.5   Australia
               10.2.5.1  Market Trends
               10.2.5.2  Market Forecast
          10.2.6   Indonesia
               10.2.6.1  Market Trends
               10.2.6.2  Market Forecast
          10.2.7   Others
               10.2.7.1  Market Trends
               10.2.7.2  Market Forecast
     10.3   Europe
          10.3.1   Germany
               10.3.1.1  Market Trends
               10.3.1.2  Market Forecast
          10.3.2   France
               10.3.2.1  Market Trends
               10.3.2.2  Market Forecast
          10.3.3   United Kingdom
               10.3.3.1  Market Trends
               10.3.3.2  Market Forecast
          10.3.4   Italy
               10.3.4.1  Market Trends
               10.3.4.2  Market Forecast
          10.3.5   Spain
               10.3.5.1  Market Trends
               10.3.5.2  Market Forecast
          10.3.6   Russia
               10.3.6.1  Market Trends
               10.3.6.2  Market Forecast
          10.3.7   Others
               10.3.7.1  Market Trends
               10.3.7.2  Market Forecast
     10.4   Latin America
          10.4.1   Brazil
               10.4.1.1  Market Trends
               10.4.1.2  Market Forecast
          10.4.2   Mexico
               10.4.2.1  Market Trends
               10.4.2.2  Market Forecast
          10.4.3   Others
               10.4.3.1  Market Trends
               10.4.3.2  Market Forecast
     10.5   Middle East and Africa
          10.5.1  Market Trends
          10.5.2  Market Breakup by Country
          10.5.3  Market Forecast
11    SWOT Analysis
    11.1   Overview
    11.2   Strengths
    11.3   Weaknesses
    11.4   Opportunities
    11.5   Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1   Overview
    13.2   Bargaining Power of Buyers
    13.3   Bargaining Power of Suppliers
    13.4   Degree of Competition
    13.5   Threat of New Entrants
    13.6   Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1   Market Structure
    15.2   Key Players
    15.3   Profiles of Key Players
         15.3.1   Biogen
              15.3.1.1   Company Overview
              15.3.1.2   Product Portfolio
              15.3.1.3   Financials
              15.3.1.4   SWOT Analysis
         15.3.2   Boehringer Ingelheim International GmbH
              15.3.2.1   Company Overview
              15.3.2.2   Product Portfolio
              15.3.2.3   Financials
              15.3.2.4   SWOT Analysis
         15.3.3   F. Hoffmann-La Roche AG
              15.3.3.1   Company Overview
              15.3.3.2   Product Portfolio
              15.3.3.3   Financials
         15.3.4   GlaxoSmithKline Plc 
              15.3.4.1   Company Overview
              15.3.4.2   Product Portfolio
              15.3.4.3   SWOT Analysis
         15.3.5   Merck & Co. Inc.
              15.3.5.1   Company Overview
              15.3.5.2   Product Portfolio
              15.3.5.3   Financials
              15.3.5.4   SWOT Analysis
         15.3.6   Novartis AG
              15.3.6.1   Company Overview
              15.3.6.2   Product Portfolio
              15.3.6.3   Financials
              15.3.6.4   SWOT Analysis
         15.3.7   Pfizer Inc.
              15.3.7.1   Company Overview
              15.3.7.2   Product Portfolio
              15.3.7.3   Financials
              15.3.7.4   SWOT Analysis
         15.3.8   Sanofi S.A
              15.3.8.1   Company Overview
              15.3.8.2   Product Portfolio
              15.3.8.3   Financials
              15.3.8.4   SWOT Analysis
         15.3.9   Teva Pharmaceutical Industries Ltd.
              15.3.9.1   Company Overview
              15.3.9.2   Product Portfolio
              15.3.9.3   Financials
              15.3.9.4   SWOT Analysis
         15.3.10   UCB S.A
              15.3.10.1   Company Overview
              15.3.10.2   Product Portfolio
              15.3.10.3   Financials
              15.3.10.4   SWOT Analysis

List of Figures

Figure 1: Global: Neurodegenerative Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Neurodegenerative Disease Treatment Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Neurodegenerative Disease Treatment Market: Breakup by Indication (in %), 2020
Figure 5: Global: Neurodegenerative Disease Treatment Market: Breakup by Drug Type (in %), 2020
Figure 6: Global: Neurodegenerative Disease Treatment Market: Breakup by Route of Administration (in %), 2020
Figure 7: Global: Neurodegenerative Disease Treatment Market: Breakup by Distribution Channel (in %), 2020
Figure 8: Global: Neurodegenerative Disease Treatment Market: Breakup by Region (in %), 2020
Figure 9: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market: Sales Value (in Million US$), 2015-2020
Figure 10: Global: Neurodegenerative Disease Treatment (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Neurodegenerative Disease Treatment (Parkinsons Disease) Market: Sales Value (in Million US$), 2015-2020
Figure 12: Global: Neurodegenerative Disease Treatment (Parkinsons Disease) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Neurodegenerative Disease Treatment (Alzheimers Disease) Market: Sales Value (in Million US$), 2015-2020
Figure 14: Global: Neurodegenerative Disease Treatment (Alzheimers Disease) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market: Sales Value (in Million US$), 2015-2020
Figure 16: Global: Neurodegenerative Disease Treatment (Spinal Muscular Atrophy- SMA) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Neurodegenerative Disease Treatment (Huntingtons Disease) Market: Sales Value (in Million US$), 2015-2020
Figure 18: Global: Neurodegenerative Disease Treatment (Huntingtons Disease) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2015-2020
Figure 20: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor antagonists) Market: Sales Value (in Million US$), 2015-2020
Figure 22: Global: Neurodegenerative Disease Treatment (N-methyl-D-aspartate Receptor antagonists) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million US$), 2015-2020
Figure 24: Global: Neurodegenerative Disease Treatment (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market: Sales Value (in Million US$), 2015-2020
Figure 26: Global: Neurodegenerative Disease Treatment (Dopamine Inhibitors) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2015-2020
Figure 28: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Neurodegenerative Disease Treatment (Oral) Market: Sales Value (in Million US$), 2015-2020
Figure 30: Global: Neurodegenerative Disease Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Neurodegenerative Disease Treatment (Injectable) Market: Sales Value (in Million US$), 2015-2020
Figure 32: Global: Neurodegenerative Disease Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2015-2020
Figure 34: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015-2020
Figure 36: Global: Neurodegenerative Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2015-2020
Figure 38: Global: Neurodegenerative Disease Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Global: Neurodegenerative Disease Treatment (Others) Market: Sales Value (in Million US$), 2015-2020
Figure 40: Global: Neurodegenerative Disease Treatment (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: North America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 42: North America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: North America: Neurodegenerative Disease Treatment Market: Breakup by Country (in %), 2020
Figure 44: United States: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 45: United States: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Canada: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 47: Canada: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Asia-Pacific: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 49: Asia-Pacific: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Asia-Pacific: Neurodegenerative Disease Treatment Market: Breakup by Country (in %), 2020
Figure 51: China: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 52: China: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Japan: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 54: Japan: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: India: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 56: India: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: South Korea: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 58: South Korea: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Australia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 60: Australia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Indonesia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 62: Indonesia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 64: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Europe: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 66: Europe: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Europe: Neurodegenerative Disease Treatment Market: Breakup by Country (in %), 2020
Figure 68: Germany: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 69: Germany: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: France: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 71: France: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: United Kingdom: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 73: United Kingdom: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Italy: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 75: Italy: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Spain: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 77: Spain: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Russia: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 79: Russia: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 81: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Latin America: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 83: Latin America: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Latin America: Neurodegenerative Disease Treatment Market: Breakup by Country (in %), 2020
Figure 85: Brazil: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 86: Brazil: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Mexico: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 88: Mexico: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 89: Others: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 90: Others: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 91: Middle East and Africa: Neurodegenerative Disease Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 92: Middle East and Africa: Neurodegenerative Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 93: Middle East and Africa: Neurodegenerative Disease Treatment Market: Breakup by Country (in %), 2020
Figure 94: Global: Neurodegenerative Disease Treatment Industry: SWOT Analysis
Figure 95: Global: Neurodegenerative Disease Treatment Industry: Value Chain Analysis
Figure 96: Global: Neurodegenerative Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Neurodegenerative Disease Treatment Market: Key Industry Highlights, 2021 and 2026
Table 2: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Indication (in Million US$), 2021-2026
Table 3: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2021-2026
Table 4: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 5: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: Global: Neurodegenerative Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Neurodegenerative Disease Treatment Market: Competitive Structure
Table 8: Global: Neurodegenerative Disease Treatment Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links